---
title: "“Excellent” one-year outcomes from ROADSTER 3 show TCAR is “safe and effective”"
date: "2025-11-04T17:00:16.000Z"
publishedDate: "4 novembre 2025"
summary: "One-year outcomes in the ROADSTER 3 post-approval study to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) using the Enroute stent and neuroprotection system (Boston Scientific) in standard-surgical-risk patients revealed a 1.5% intention-to-treat rate of composite major adverse events (1.3% per protocol). Delivering the results at the 2025 Vascular Interventional Advances (VIVA) conference (2–5 November, [&#8230;] The post &#8220;Excellent&#8221; one-year outcomes from ROADSTER 3 show TCAR is &#8220;safe and effective&#8221; appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/excellent-one-year-outcomes-from-roadster-3-show-tcar-is-safe-and-effective/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-11-04-excellent-one-year-outcomes-from-roadster-3-show-tcar-is-safe-and-effective"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/11/Megain-Dermody-VIVA-2025-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/excellent-one-year-outcomes-from-roadster-3-show-tcar-is-safe-and-effective/"
---

![“Excellent” one-year outcomes from ROADSTER 3 show TCAR is “safe and effective”](https://vascularnews.com/wp-content/uploads/sites/7/2025/11/Megain-Dermody-VIVA-2025-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/excellent-one-year-outcomes-from-roadster-3-show-tcar-is-safe-and-effective/*

## L’essentiel

One-year outcomes in the ROADSTER 3 post-approval study to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) using the Enroute stent and neuroprotection system (Boston Scientific) in standard-surgical-risk patients revealed a 1.5% intention-to-treat rate of composite major adverse events (1.3% per protocol). Delivering the results at the 2025 Vascular Interventional Advances (VIVA) conference (2–5 November, [&#8230;] The post &#8220;Excellent&#8221; one-year outcomes from ROADSTER 3 show TCAR is &#8220;safe and effective&#8221; appeared first on Vascular News .

## Lien source

https://vascularnews.com/excellent-one-year-outcomes-from-roadster-3-show-tcar-is-safe-and-effective/
